FDA Inspection
IDT Biologika GmbHIDT Biologika GmbH – FDA Inspection, Mar 8, 2019
Record Details
This FDA Inspection record concerns IDT Biologika GmbH, with an inspection on March 8, 2019, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · b278e54c-8921-4c5f-a381-4160306b266a
Inspection Facts
- Inspection number
- 1084145
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of IDT Biologika GmbH
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2026 | Not classified | Office of Inspections and Investigations | Human Cellular, Tissue, and Gene Therapies |
| September 8, 2023 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 25, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 10, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for IDT Biologika GmbH
- FDA Inspection 1335726 - 2026-09-15
- FDA Inspection 1217129 - 2023-09-08
- FDA Inspection 1277176 - 2023-08-25
- FDA Inspection 1143607 - 2020-09-10
- FDA Inspection 994505 - 2016-11-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.